Raw database. by Franco Romaní-Romaní (21989788)

“…<div><p>Background</p><p>Progress testing is a longitudinal assessment method used to monitor the acquisition and retention of knowledge throughout medical training. …”

Receiver-operating characteristic curves of % PCT decrease for predicting survival (A) and recovery from dialysis (B) within 28 days after CRRT initiation in patients with SIAKI re... by Il Young Kim (10757390)

Percentage of the predicted <i>CYP2C19</i> (A), <i>CYP3A5</i> (B), <i>DPYD</i> (C), <i>CYP2C9</i> (D), <i>TPMT</i> (E), <i>NUDT15</i> (F) metabolizer groups. by Ewa Goljan (3463487)

Subjects:

Table_1_A T3SS Regulator Mutant HY9901 ΔaraC of Vibrio alginolyticus Decreased the Expression of HopPmaJ and Provided Protection to Danio rerio as a Live-Attenuated Vaccine.xls by Junlin Wang (4029803)

“…The swimming ability of ΔaraC decreased and exhibited a 2,600 times reduction in virulence to zebrafish. …”

Image_2_Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals.tif by Liina Tserel (420665)

“…We here studied the antibody and T cell responses, and a wide range of inflammation markers, in 56 SARS-CoV-2 antibody-positive individuals, identified by a population screen after the first wave of SARS-CoV-2 infection. …”

Image_3_Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals.tif by Liina Tserel (420665)

“…We here studied the antibody and T cell responses, and a wide range of inflammation markers, in 56 SARS-CoV-2 antibody-positive individuals, identified by a population screen after the first wave of SARS-CoV-2 infection. …”

Image_1_Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals.tif by Liina Tserel (420665)

“…We here studied the antibody and T cell responses, and a wide range of inflammation markers, in 56 SARS-CoV-2 antibody-positive individuals, identified by a population screen after the first wave of SARS-CoV-2 infection. …”

Adverse events and treatment interruptions. by Nicola Squillace (691608)

“…At T1, ART-experienced PLWH showed a significant reduction of total cholesterol (TC) and triglycerides, and a slight increase in blood glucose (BG) and ALT. …”

Flow chart of the treatment interruptions. by Nicola Squillace (691608)

“…At T1, ART-experienced PLWH showed a significant reduction of total cholesterol (TC) and triglycerides, and a slight increase in blood glucose (BG) and ALT. …”

Morphine decreases neuronal excitability in enteric AHP +ve neurons without changing the resting membrane potential. by Tricia H. Smith (306217)

“…Statistical analysis (D) indicates that morphine (3 µM) causes a significant increase in threshold and a decrease in action potential height (taken at 30% height at 0.09 nA current injection) while leaving the resting membrane potential unaffected (* = p<0.05 via t-test). n = 6 for all analyses. …”

UV-B impairs PIF4 binding to shade marker genes’ promoters in a UVR8-dependent manner. by Eleni Tavridou (8822789)

Genes whose expression was decreased by 100 nM ouabain by more than 1.3-fold. by Larisa V. Smolyaninova (3600053)

Immune challenge increases the intensity of some Ni-Sp185/333 proteins and decreases the intensity of others. by Lauren S. Sherman (800584)

“…(B) After challenge with <i>V</i>. <i>diazotrophicus</i>, larger MW proteins decrease in intensity (compare white arrows in A and B), whereas the monomers increase in intensity (compare black arrows in A and B).…”

PA J10 mutant does not affect the formation of VLPs but decreases viral RNA packaging efficiency. by Yuhong Liang (335908)

GRIP1^-/- platelets do not have decreased velocity in ionophore-stimulated blood vessels. by Kristina L. Modjeski (3123072)

“…<p>A) GRIP1^-/- platelets do not have a decreased velocity in an ionophore-stimulated pinna vessel. …”

Diagram showing some of the factors that mediate cytokin storm following infection with COVID-19. by Joseph Rabin (7399436)

Subjects:

Antibodies used for flow cytometry experiments. by Joseph Rabin (7399436)

Subjects:

Changes of plasma proinflammatory cytokines/chemokines during and after RA infusion. by Joseph Rabin (7399436)

Subjects:

Demographics of the COVID-19 patients who received regadenoson treatment. by Joseph Rabin (7399436)

Subjects:

Subject flow diagram. by Joseph Rabin (7399436)

Subjects: